Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Fervent Synergies Ltd (FERVENTSYN) Share Price & Fundamentals

Company Overview

Founded Year

2009

Listed Year

2012

Headquarter

Mumbai, India

MD/CEO

Mr. Sanjay Thakkar

Website

http://www.ferventsynergies.com

Company Facts

What we do

Fervent Synergies Ltd deals in pharmaceutical and chemical products, focusing on import-export, trading, and distribution of chemicals, solvents, APIs, intermediates, and bulk drugs.

Founded in

2,009

Market share

Listed on BSE, the company holds a niche in pharmaceutical chemical distribution with a growing Foods and Finance segment.

Problem solved

Provides reliable sourcing and distribution of pharmaceutical-grade chemicals and food products, ensuring supply chain stability.

Top clients or who we serve

Primarily serves pharmaceutical manufacturers and food industry players; focused on B2B markets.

Key management

Mr. Sanjay Thakkar (Managing Director), Mr. Karan Thakkar (CFO), Mrs. Nehal Jain (Company Secretary).

Our journey and innovations

Started as Fervent Pharma Synergies in 2009, merged with Midas Pharmasec in 2010; equity listed in 2012; expanded into Foods and Finance divisions.

Where we operate

Primarily operates within India with import-export activities; listed on Bombay Stock Exchange.

Top products or what we offer

Pharmaceutical chemicals, solvents, APIs, intermediates, almond food products, and financial services.

Top brands

Foods Division (Almonds and related products), Finance Division (small finance services).

Raw materials needed

Pharmaceutical chemicals, solvents, raw bulk drugs for trading and distribution.

Raw materials supplier

Various domestic and international chemical manufacturers and suppliers.

Recurring vs cyclical contribution

Revenues are a mix of recurring trading operations and cyclical finance segment contributions.

Our industry position

Niche player listed on BSE with steady revenue growth and expanding business segments.

Financial highlights

FY 2025 Revenue Rs. 32.46 crore; Net Profit Rs. 2.95 crore; turnaround from prior year loss.

Geographical revenue split

Revenue primarily from India with some export-import activities.

Order book

-

Whats driving growth

Growth driven by rising demand in pharmaceuticals and food sectors, preferential share allotments, and financial services expansion.

Our future plans

Focus on consolidating Foods and Finance divisions, leveraging capital infusion and market demand.

Our green promise

-

Our people and values

Small employee base with emphasis on ethical conduct and zero tolerance for corruption.

Key challenges ahead

Supply chain uncertainties due to geopolitical factors and regulatory compliance in finance sector.

Interesting facts

Company reversed prior losses with net profit in FY 2025 following strategic capital increases.

Risks and strategy

Managing supply risks and regulatory challenges through diversified segments and strong governance.

Market Footprint

Top Clients

Top Clients

Primarily serves pharmaceutical manufacturers and food industry players; focused on B2B markets.

Top Products

Top Products

Pharmaceutical chemicals, solvents, APIs, intermediates, almond food products, and financial services.

Price Movement & Share Holding

Today's High/Low

16.516.65

52 Week High/Low

13.0526
Past Returns

1 week

17.94%

1 month

8.06%

3 month

0.43%

1 year

-20.56%

3 year

-13.16%

5 year

4.1%

Share Holding

Promoters

74.75%

FII

0%

DII

0%

Retail

8.54%

Others

16.71%

Company Overview

Founded Year

2009

Listed Year

2012

Headquarter

Mumbai, India

MD/CEO

Mr. Sanjay Thakkar (Managing Director)

Website

http://www.ferventsynergies.com

Price Movement & Share Holding

Today's High/Low

16.516.65

52 Week High/Low

13.0526

Past Returns

1 week

17.94%

1 month

8.06%

3 month

0.43%

1 year

-20.56%

3 year

-13.16%

5 year

4.1%

Share Holding

Promoters

74.75%

FII

0%

DII

0%

Retail

8.54%

Others

16.71%

Company Facts

What we do

Fervent Synergies Ltd deals in pharmaceutical and chemical products, focusing on import-export, trading, and distribution of chemicals, solvents, APIs, intermediates, and bulk drugs.

Founded in

2009

Market share

Listed on BSE, the company holds a niche in pharmaceutical chemical distribution with a growing Foods and Finance segment.

Problem solved

Provides reliable sourcing and distribution of pharmaceutical-grade chemicals and food products, ensuring supply chain stability.

Top clients or who we serve

Primarily serves pharmaceutical manufacturers and food industry players; focused on B2B markets.

Key management

Mr. Sanjay Thakkar (Managing Director), Mr. Karan Thakkar (CFO), Mrs. Nehal Jain (Company Secretary).

Our journey and innovations

Started as Fervent Pharma Synergies in 2009, merged with Midas Pharmasec in 2010; equity listed in 2012; expanded into Foods and Finance divisions.

Where we operate

Primarily operates within India with import-export activities; listed on Bombay Stock Exchange.

Top products or what we offer

Pharmaceutical chemicals, solvents, APIs, intermediates, almond food products, and financial services.

Top brands

Foods Division (Almonds and related products), Finance Division (small finance services).

Raw materials needed

Pharmaceutical chemicals, solvents, raw bulk drugs for trading and distribution.

Raw materials supplier

Various domestic and international chemical manufacturers and suppliers.

Recurring vs cyclical contribution

Revenues are a mix of recurring trading operations and cyclical finance segment contributions.

Our industry position

Niche player listed on BSE with steady revenue growth and expanding business segments.

Financial highlights

FY 2025 Revenue Rs. 32.46 crore; Net Profit Rs. 2.95 crore; turnaround from prior year loss.

Geographical revenue split

Revenue primarily from India with some export-import activities.

Whats driving growth

Growth driven by rising demand in pharmaceuticals and food sectors, preferential share allotments, and financial services expansion.

Our future plans

Focus on consolidating Foods and Finance divisions, leveraging capital infusion and market demand.

Our people and values

Small employee base with emphasis on ethical conduct and zero tolerance for corruption.

Key challenges ahead

Supply chain uncertainties due to geopolitical factors and regulatory compliance in finance sector.

Interesting facts

Company reversed prior losses with net profit in FY 2025 following strategic capital increases.

Risks and strategy

Managing supply risks and regulatory challenges through diversified segments and strong governance.

Market Footprint

Top Clients

Top Clients

Primarily serves pharmaceutical manufacturers and food industry players; focused on B2B markets.

Top Products

Top Products

Pharmaceutical chemicals, solvents, APIs, intermediates, almond food products, and financial services.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions